← All organizations

Talaris Therapeutics

For profitWebsite ↗

Also known as: Talaris Therapeutics | Talaris Therapeutics Inc. | Tourmaline Bio, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 15, 2024

Timeline

2000s

Jun 1, 2002
Talaris Therapeutics— Founded

Drugs by trial phase (3 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

fcr001

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Renal Insufficiency

Recent trials (8)

NCT06362759Lead sponsorPhase 2May 15, 2024
NCT06088979Lead sponsorPhase 2Dec 31, 2023
NCT05098145Study directorPhase 1/Phase 2Nov 30, 2021
NCT05098145Lead sponsorPhase 1/Phase 2Nov 30, 2021
NCT03995901Lead sponsorPhase 3Jul 31, 2019
NCT03995901Study directorPhase 3Jul 31, 2019
NCT01649388CollaboratorPhase 1/Phase 2May 1, 2012
NCT00497926CollaboratorPhase 2Mar 1, 2008

Details

Founded: Louisville, KY, US Jun 1, 2002
Last known activity: May 15, 2024

Notes

founded Regenerex, LLC